These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25645222)

  • 1. SNMMI leadership update: Clinical Trials Network: from clinical trials to practice.
    Pappas V
    J Nucl Med; 2015 Feb; 56(2):12N. PubMed ID: 25645222
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of penile metastases of prostatic origin with 11C-Choline PET/CT.
    Garcia JR; Aguilo JJ; Marco V; Valls E; Soler M; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):295-6. PubMed ID: 22682926
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of prostate cancer relapse with PET/CT using a novel radiotracer.
    Lilleby W; Willoch F; Stensvold A
    Acta Oncol; 2012 Mar; 51(3):397-9. PubMed ID: 21936756
    [No Abstract]   [Full Text] [Related]  

  • 4. SNMMI Leadership Update: Clinical Trials Network Update.
    Pappas V
    J Nucl Med; 2016 Feb; 57(2):13N. PubMed ID: 26833909
    [No Abstract]   [Full Text] [Related]  

  • 5. How does endorectal MRI, PET-CT and transrectal ultrasound contribute to diagnosis and management of localized prostate cancer.
    Rincón Mayans A; Diaz-Tejeiro BZ; Rioja Zuazu J; Díaz Dorronsoro L; Rodriguez Fraile M; Boillos AB; Bergera JZ
    Arch Esp Urol; 2011 Oct; 64(8):746-64. PubMed ID: 22052757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer.
    Paone G; Treglia G; Bongiovanni M; Ruberto T; Ceriani L; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):340-1. PubMed ID: 23796426
    [No Abstract]   [Full Text] [Related]  

  • 7. FDG in Urologic Malignancies.
    Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
    PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of small cell carcinoma of the prostate.
    Sahiner I; Akkas BE; Ucmak Vural G
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):193-5. PubMed ID: 23218515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PET, PET-CT].
    Oyama N; Yokoyama O
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():280-4. PubMed ID: 22207986
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of FDG PET-CT in prostate lesion diagnosis.
    Radiol Technol; 2014; 85(5):546M-547M. PubMed ID: 24806072
    [No Abstract]   [Full Text] [Related]  

  • 11. PET/CT in prostate cancer: an unmet clinical need.
    Mintz A
    Oncology (Williston Park); 2014 Dec; 28(12):1065-6. PubMed ID: 25738198
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous rectal schwannoma and prostatic adenocarcinoma detected on FDG PET/CT.
    Wu YC; Hsieh TC; Kao CH; Yen KY; Sun SS
    Clin Nucl Med; 2011 Oct; 36(10):948-9. PubMed ID: 21892058
    [No Abstract]   [Full Text] [Related]  

  • 13. Superscan pattern of F-18 sodium fluoride PET/CT study in a case of prostate cancer.
    Li Y; Tafti BA; Shaba W; Berenji GR
    Clin Nucl Med; 2011 Nov; 36(11):1046-8. PubMed ID: 21975402
    [No Abstract]   [Full Text] [Related]  

  • 14. [Update on the use of radiopharmaceuticals for positron emission tomography imaging of prostate cancer].
    García JR
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):177-86. PubMed ID: 23499125
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo visualization of somatostatin receptor expression with Ga-68-DOTA-TATE PET/CT in advanced metastatic prostate cancer.
    Alonso O; Gambini JP; Lago G; Gaudiano J; Quagliata A; Engler H
    Clin Nucl Med; 2011 Nov; 36(11):1063-4. PubMed ID: 21975409
    [No Abstract]   [Full Text] [Related]  

  • 16. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0.
    Dorbala S; Di Carli MF; Delbeke D; Abbara S; DePuey EG; Dilsizian V; Forrester J; Janowitz W; Kaufmann PA; Mahmarian J; Moore SC; Stabin MG; Shreve P
    J Nucl Med; 2013 Aug; 54(8):1485-507. PubMed ID: 23781013
    [No Abstract]   [Full Text] [Related]  

  • 17. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
    Koo PJ; David Crawford E
    Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choline PET/CT for imaging prostate cancer: an update.
    Kitajima K; Murphy RC; Nathan MA
    Ann Nucl Med; 2013 Aug; 27(7):581-91. PubMed ID: 23632880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
    Bouchelouche K; Oehr P
    J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply: To PMID 22343504.
    Adler S; Kurdziel K; Lindenberg L; Choyke P; Mena E
    J Nucl Med; 2013 Feb; 54(2):326-7. PubMed ID: 23487863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.